Bloom's syndrome (BS) is a rare autosomal recessive disorder characterized by genomic instability and cancer predisposition. The underlying genetic defect is mutation of the BLM gene, producing deficiency in the RecQ helicase BLM (Bloom's syndrome protein). The present article begins by introducing BLM and its binding partners before reviewing its known biochemical activities and its potential roles both as a prorecombinase and as a suppressor of homologous recombination. Finally, the evidence for an emerging role in mitotic chromosome segregation is examined.
BLM and its binding partners
The RecQ family, of which BLM is a member, is evolutionarily conserved from bacteria to humans. This conservation is most striking in the centrally located helicase domain, which contains the seven characteristic consensus motifs typifying Superfamily II helicases. BLM contains two additional domains, conserved in both Escherichia coli RecQ and the Saccharomyces cerevisiae orthologue, Sgs1. The RQC (RecQ C-terminal) domain appears to be important for ATPase activity, DNA-binding and helicase function [7] . It includes a Zn 2+ -binding region containing four conserved cysteine residues, mutation of two of which gives rise to BS [8] , as well as a winged-helix motif also found in proteins outside the RecQ helicase family that are known to interact with DNA. The HRDC (helicase and RNaseD C-terminal) domain confers DNA structure specificity and is essential for the ability to bind to and unwind DHJs (double Holliday junctions) [9] (see below). The N-terminal domain of BLM is likely to mediate many of the interactions between BLM and other proteins, as well as being an important regulatory domain. Post-translational modification, including phosphorylation and SUMOylation, affects both the intracellular localization and the function of BLM.
It is known that the physical interaction of BLM with other specific nuclear proteins is required for it to fulfil some of its functions. In mammalian cells, BLM binds directly to the DNA decatenase topoisomerase III [10] and hRMI1 (BLAP75) [11] in a co-operative relationship conserved between homologous proteins in other organisms, including Schizosaccharomyces pombe (Rqh1, Top3, Rmi1 proteins) and S. cerevisiae (Sgs1, Top3 and Rmi1 proteins) (reviewed in [12] ). More recently, a fourth candidate member, RMI2 (BLAP18) has been identified, which appears to play a critical role in complex stability [13, 14] . There is close functional interdependency between the components of this BTR (BLM-topoisomerase III-RMI1/2) multiprotein complex. BLM stimulates topoisomerase III to relax negatively supercoiled DNA [15] , whereas depletion of hRMI1, using siRNA (short interfering RNA), leads to impaired BLM focus formation at sites of DNA damage, an increase in SCEs and defective cell proliferation [11] . hRMI2 is similarly required for correct BLM localization following replication blockade. In the absence of hRMI2, cells exhibit an increase in spontaneous chromosome breaks [14] . It is likely that BLM fulfils the majority of its roles within the context of these binding partners. However, it seems that there are also circumstances in which BLM can act independently. For instance, camptothecin-induced replication arrest is followed by disruption of the BTR complex and dissociation of BLM from topoisomerase III [16] . BLM is also known to interact with the recombinase Rad51 [17] and can bind to the ssDNA (single-stranded DNA)-binding protein RPA (replication protein A), in a reaction that efficiently stimulates BLM helicase activity [18] .
Multiple enzymatic properties of BLM have been demonstrated in vitro. In common with many RecQ helicases, the 3 →5 helicase activity of BLM is Mg 2+ -and ATP-dependent and DNA-structure-specific. Although it can unwind a wide variety of structures, its efficiency is greatest when unwinding certain complex or forked DNA structures, including D-loops (displacement loops), duplexes with internal 'bubbles' and G-quadruplexes [19, 20] , suggesting that it is these which form its preferred physiological substrate. RecQ helicases, including BLM, also possess the ability to catalyse the reverse reaction to that of a helicase, promoting the annealing of complementary single strands of DNA in an Mg 2+ -independent reaction that is dependent on the C-terminal domain and is inhibited by ssDNA-binding proteins [21] . The ATPase activity of BLM is strongly dependent on the presence of ssDNA [22] , reminiscent of yeast Srs2 [23] .
Determining the in vivo roles of BLM is proving more complex. Mutations in BLM cause a hyper-recombination phenotype [1] , implying that BLM functions to suppress recombination. However, BLM has also been implicated in the promotion of both early and late steps in the process of HR-mediated replication fork repair. These apparently conflicting roles appear to coexist. A priority must be to establish which of the many potential functions of BLM are critical in suppressing chromosomal instability and which can be undertaken either by other members of the RecQ helicase family or, indeed, by other DNA helicases, such as those belonging to the UvrD/Srs2/Fbh1 family.
Below, we summarize the putative pro-recombinogenic and anti-recombinogenic roles for BLM before focusing in more detail on the emerging role for BLM in mitotic chromosome segregation.
Pro-recombinogenic roles of BLM
The HR-mediated repair of a DSB (double-strand break) is initiated by 5 →3 resection of the DSB ends, to produce a region of ssDNA, followed by the Rad51-dependent invasion of the 3 -end of the DSB into an intact homologous duplex (usually the sister chromatid) to form a D-loop ( Figure 1 ). BLM appears to promote resection and can stimulate the nucleolytic activity of hExo1 (human exonuclease 1), a double-stranded exonuclease probably responsible for processing the DSB ends into ssDNA in readiness for assembly of the nucleofilament proteins [24, 25] . This activity of BLM is mediated independently of its helicase activity and is evidence that BLM has a very early role in the initiation of HR. Generation of regions of ssDNA are also critical for the induction of robust cell-cycle checkpoint signalling, including the recruitment of proteins such as BRCA1 (breast cancer 1 early-onset), NBS1 (Nijmegen breakage syndrome protein 1) and DNA-damage-checkpoint mediators such as 53BP1 (p53-binding protein 1). Protein recruitment to stalled forks is delayed or absent in BS cells following exposure to hydroxyurea [26] , a defect which is reversed by expression of a helicase-defective form of BLM [26] .
The ATPase activity of RecQ helicases becomes critical in intra-S-phase checkpoint functions, including the stabilization and subsequent HR-dependent restart of arrested replication forks [27] . It has been suggested that BLM has a role in the processing of stalled forks to produce a configuration that permits restart of replication, potentially by promoting fork regression [28] . This process uses 'template switching' in which the nascent lagging strand is used as a template to extend the leading strand past the site of damage. A one-ended DSB is generated that can be processed to facilitate HR-mediated replication restart. This possible role for BLM is supported by the fact that BLM helicase activity is essential for maintaining arrested forks in a state competent for replication restart following transient exposure to aphidicolin [29] and is consistent with the requirement for the helicase activity of the S. cerevisiae RecQ helicase for the continued association of DNA polymerases and with arrested replication forks [30] . Although HR-independent pathways exist for circumventing lesions that have induced stalled replication forks, collapsed replication forks resulting from the collision of a fork with a single-strand break in the template are totally dependent on HR for their recovery. Hence BLM has a critical role in maintaining the fidelity of HR early in the process.
It is established that BLM also has a role in the terminal stages of HR. This is suggested by the accumulation of HRdependent recombination intermediates resembling Holliday junctions in Sgs1-deficient S. cerevisiae [31] . Holliday junctions must be processed to permit chromosome segregation and this can be achieved by at least two pathways ( Figure 1 ). The classical pathway of Holliday junction resolution involves the symmetrical nicking of one of the pairs of identical strands of the same polarity at the crossover point of a Holliday junction. E. coli RuvC was the first cellular nuclease identified as acting as a Holliday junction resolvase capable of promoting this process. The RuvC-like pathway of Holliday junction resolution allows the nicked duplex DNA to be ligated with no need for additional processing. Resolution products can be either crossover or non-crossover, depending on which pair of strands is nicked. Recently, it has been proposed that the human nuclease GEN1 and its S. cerevisiae orthologue Yen1 fulfil the role of Holliday junction resolvases in their respective species [32] . Steps in the various pathways where BLM might act are indicated by green stars. FBH1, F-box DNA helicase 1; hExo1, human exonuclease 1; hTOPIIIα, human topoisomerase IIIα.
An alternative terminal mechanism in HR is Holliday junction dissolution, which occurs only when a DHJ structure is generated. Within the context of the BTR complex, BLM is able to mediate the convergence and subsequent collapse of the two Holliday junctions into a hemicatenane structure (Figure 1 ) [33, 34] in a process that is dependent on the HRDC domain [9] . The DNA singlestrand passage activity of hTopoIII (human topoisomerase III) decatenates the structure, assisted by hRMI1 [35, 34] . Work in Drosophila on the orthologous proteins suggests that RPA may additionally stimulate the helicase activity of BLM [36] . This novel mechanism of processing Holliday junctions has the significant advantage that the products generated are exclusively non-crossover [33] . Dissolution provides BLM with a potential role late in HR for suppressing crossing-over, which would minimize LOH (loss of heterozygosity) and prevent unwanted genomic rearrangements. In the absence of BLM, processing of DHJs must proceed by the classical RuvC-like resolution pathway, giving rise to the crossovers [37] and elevated SCEs seen in BS cells [4] . The catalysis of dissolution is highly specific for BLM, which cannot be replaced by other RecQ helicases [9] . Consistent with this is the fact that hypomorphic BLM-mediated knockout mice cells show LOH [38] . In most HR reactions, the sequence homology between sister chromatids ensures that sequence alteration is avoided and crossovers have minimal physiological significance. However, when non-sisters or non-allelic loci are used as the template for repair, the consequent genomic rearrangements risk the stability of the genome. It is in this situation that the promotion of alternative pathways of repair by BLM that produce non-crossover products, such as synthesis-dependent strand annealing and Holliday junction dissolution, have a critical role in preserving chromosomal integrity.
Anti-recombinogenic roles

D-loop destruction
The D-loop structure represents the initial strand-invasion step of HR (Figure 1 ) and is a common intermediate in most models for recombination-mediated DNA-repair processes. BLM possesses the ability to disrupt D-loops generated by the RecA recombinase, with the invading strand being displaced from the duplex with high efficiency [19, 39] . This may represent a mechanism for the suppression of HR by BLM [19] , potentially to avoid inappropriate template usage and may be facilitated in vivo by the physical association of BLM and Rad51 [17] .
Alternatively, it has been proposed that BLM-mediated D-loop dissociation after primer extension by DNA polymerase might be a necessary step before re-annealing of two ends of the broken DNA molecule during DSB repair [22, 40] . This would place BLM in the position of promoting HR via synthesis-dependent strand annealing, a pathway that prevents the formation of crossovers and hence SCEs [41] (Figure 1 ). Co-ordination between these roles may be achieved by the fact that BLM cannot dissociate D-loops when hRad51 is present in an active ATP-bound conformation in the presence of Ca 2+ [22] , minimizing the risk of premature disruption of D-loops before completion of the primer extension by DNA polymerase. In the absence of sufficient DNA polymerase, D-loop dissociation would require conversion of the hRad51 filament into an inactive ADP-bound form.
Disruption of Rad51 nucleofilaments
Disruption of the Rad51-ssDNA filament offers an appealing potential mechanism for the early suppression of inappropriate HR. Filament disruption results in inhibition of DNAstrand exchange. Low concentrations of BLM helicase can efficiently disrupt the nucleofilament by displacing hRad51 protein from ssDNA in an ATPase-dependent manner [22] , in a manner reminiscent of other DNA helicases, including RecQL5 [42] and the yeast DNA helicase Srs2 [23] . Consistent with the notion of functional redundancy is the fact that overexpression of the sole yeast RecQ orthologue Sgs1 can suppress recombination defects observed in S. cerevisiae Srs2-deletion mutants [43, 44] . Regulation of this role for BLM may be achieved by a similar mechanism to the regulation of D-loop dissociation. BLM can only disrupt an inactive filament in its inactive ADP-bound form. Hence the nucleofilament remains susceptible to BLM dissociation until the cell is fully prepared for HR.
Mitotic roles
It is well established that even during an apparently unperturbed cell cycle, sgs1, rqh1 and top3 mutant cells display defects in chromosome segregation (reviewed in [12] ). In mammalian cells, the presence of anaphase bridges can be used as a cytological marker of chromosome mis-segregation. These represent incompletely segregated chromosomal DNA connecting the daughter nuclei, and may give rise to the generation of micronuclei as a consequence of the breakage of the bridge by mitotic spindle forces [45] . BS cells have an elevated frequency of micronuclei [6] , and it has been proposed that both anaphase bridges and micronuclei may contribute to the cancer predisposition observed in BS via the creation of gene dosage imbalances. Recently, there has been considerable focus on whether BLM has a role in the maintenance of faithful chromosome segregation at mitosis. It has been shown that loss of BLM function causes impairment in mitotic chromosome segregation and that BLM both localizes to anaphase bridges and is associated with lagging chromatin during the later stages of mitosis [46] . It may be that failure by BTR to complete Holliday junction dissolution before anaphase results in bridge formation due to persistent interlinking of the DNA molecules. Alternatively, BLM may play a role in the resolution of intertwined DNA structures arising during replication. Centromeric loci are preferentially associated with BLM-associated bridges, and this supports the proposal that at least some of the bridges represent aberrant replication structures, as does the fact that inhibition of topoisomerase II exacerbates chromosome missegregation defects in BS cells. Hence anaphase bridges may arise during replication either as fully replicated catenanes or partially replicated hemicatenated DNA arising at sites of converging replication forks [12] .
DNA bridges in anaphase are more prevalent than previously thought. A new class of UFBs (ultrafine bridges) has been reported that stain neither with conventional DNA dyes, e.g. DAPI (4 ,6-diamidino-2-phenylindole), nor with antibodies against histones. These UFBs have been observed independently in the context of staining for BLM protein [46] and the SNF2-family ATPase PICH [Plk1 (Polo-like kinase 1)-interacting checkpoint helicase] [47] . PICH is an essential component of the spindle assembly checkpoint, localizes to kinetochores and inner centromeres, and associates with ultrafine anaphase threads [47] , which are identical with the BLM-DNA bridges observed by Chan et al. [46] . These UFBs have been found with such high frequency in all cultured cell types examined so far that it has been postulated that they may represent a physiological rather than pathological process [48] .
BLM, along with its binding partners, also localizes to UFBs. These bridges persist in up to 30% of late-anaphase cells, the proportion of which can be increased by pretreatment with a topoisomerase II inhibitor [46] . The high frequency of UFBs found even in normal untreated cells supports the proposal that bridge formation is part of a physiological regulatory mechanism. Certainly, as cells progress through anaphase, a progressive reduction in the percentage of cells exhibiting bridges is observed, suggesting successful resolution before cytokinesis [46] .
The origin of UFBs is unclear. Indeed, they may not represent a uniform population. Many bridges connect sister kinetochores and probably evolve directly from catenated centromeric chromatin. Later in anaphase, longer bridges are evident and some of these may represent incompletely replicated DNA or unresolved recombination intermediates (A) FANCD2 foci localize to fragile sites on metaphase chromosomes. Co-localization of FANCD2 sister foci (green) with a FRA16D probe (red) on a metaphase chromosome 16. FANCD2 and FANCI have been shown to associate with common fragile-site loci, such as the one on chromosome 16. Paired foci can be observed as early in the cell cycle as G 2 -phase and persist throughout prophase and metaphase before segregating symmetrically. DNA is shown in blue. (B) BLM localizes to UFBs in anaphase. BLM (red) localizes to DAPI-negative UFBs in late anaphase even in normal, unperturbed, cells. Some of these show co-localization with FANCD2 foci at the bridge termini (green). These FANCD2-associated bridges are those that arise from fragile-site loci. Most of the non-FANCD2-associated bridges arise from centromeric DNA. DNA is shown in blue. [46] . The role of BLM on these bridges is also unclear. Cells lacking BLM show a higher frequency of these bridges than do isogenic cells corrected by expression of BLM [46] . BLM-deficient cells also exhibit UFBs that persist longer into anaphase than in cells expressing BLM. Although this may suggest a role for BLM in the resolution of bridges, it cannot represent the only resolution mechanism, because the bridges eventually disappear even in the absence of BLM. If BLM does play a role, it seems likely that it achieves this via its usual association with topoisomerase III and RMI1/2. This model for BLM in bridge resolution is supported by the fact that PICH staining on UFBs can be observed from metaphase [47] . However, BLM associates only from the start of anaphase [46] . Following replication, BLM and binding partners may be recruited to persistent sites of catenated DNA to facilitate faithful sister-chromatid disjunction, although most decatenation of fully replicated DNA is probably co-ordinated by topoisomerase II [47, 48] . This model for the role of BLM on the bridges is attractive because it represents an extension of the proposed role for BLM in the resolution of recombination intermediates. The role of FANCD2 in localizing to the termini of UFBs remains unknown, as does the contribution of BLM. FANCD2 possibly flags regions of the genome inadequately processed during the S/G 2 -phases of the cell cycle, which then generate UFBs in mitosis. Certainly, FANCD2 sister foci can be observed as early in the cell cycle as G 2 -phase, and these then persist throughout prophase and metaphase.
Fragile sites are hotspots for anaphase bridging
Replication inhibitors, such as aphidicolin, increase not only the percentage of cells containing UFBs in anaphase but also the number of FANCD2-associated UFBs. It may be that the absence of BLM permits aberrant bridge resolution and hence the gradual loss of tumour-suppressor function for those genes coinciding with fragile sites. The resultant genomic rearrangements and the generation of aneuploidy would be an alternative mechanism by which lack of BLM would result in a greater risk of oncogenesis.
Conclusion
BLM has many potential roles in the pathways of DNA repair and replication. Establishing which of its many biochemical properties translate into physiologically relevant functions is a daunting prospect. There is clear evidence to support a role for BLM both as a pro-recombinase and in the suppression of HR. It seems most of these conflicting roles are united in the common aim of minimizing the generation of crossover products during recombination and hence preserving genomic stability. Certainly BLM deficiency, as seen in BS, is characterized by a hyper-recombinant cellular phenotype that causes greater generation of crossover products following DSB repair and consequent loss of heterozygosity. This provides one mechanism for the cancer predisposition that is characteristic of BS. More recently, a role for BLM in mitosis was proposed on the basis of the discovery that BLM localizes both to bulky anaphase bridges and to previously undiscovered UFBs. These bridges also link sister chromatids in anaphase, and BLM may contribute to their timely resolution before cytokinesis. A role for BLM in mitotic chromosome segregation would represent a logical extension from its proven activity resolving recombination intermediates and provides an alternative mechanism for the tumorigenesis observed in BS. Chromosome mis-segregation due to inefficient resolution of anaphase bridges would potentially increase cellular aneuploidy and gene-dosage imbalances and hence increase the potential for malignant transformation.
In summary, BLM functions in multiple intracellular processes related to DNA recombination and repair, many of which remain to be clarified. The cellular and patient phenotypes observed in BS arise from the complex interplay between these roles.
